CV Company Profile and Key Details

Short-term trend indicators are mixed aligned (SMA20 2.17%, SMA50 -30.78%, SMA200 -9.41%). The stock’s 14-day RSI is 44.37 (neutral), while the ATR of 0.48 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -66.95% below its high and over 47.93% above its low. Average 10-day trading volume of 191.54 thousand shares is below the 3-month average of 386.52 thousand, indicating normal recent market interest.

CapsoVision, Inc. has 46.77 million shares outstanding. This equals 1.99 thousand shares. The short ratio is 0.05 days. Institutional investors hold 0.09% of the float. Insiders own 40.69%.

Analyst sentiment is bullish. Analyst rating data shows there are 2 Strong Buy ratings, 0 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $14.00 to $5.00. The high target offers 174.51% upside. The low target suggests -1.96% downside. The mean target is $9.50. This offers 86.27% upside. CapsoVision, Inc. earnings surprise history is a mixed track record. The quarter that ended November 13, 2025, missed forecasts by 21.43%. The prior quarter beat by 1736.36%. Over the last six quarters, Apple has recorded several small beats. These include 1736.36% in August 14, 2025.

currently trading near 52-week highs band. Valuation shows CapsoVision, Inc. trading at a premium to the broader market with a P/E of -13.09. Analyst sentiment is cautious, with the majority of ratings in Speculative Buy territory and a mean price target of $9.50, suggesting 86.27% upside.

Our AI price prediction model suggests that CapsoVision, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

CapsoVision, Inc. (NASDAQ:CV) closed at $5.20 USD, gaining $0.10 (1.96%) from the previous close of $5.10. The stock is currently mid-range between its 52-week high and low $3.43 and $15.37. With a market capitalization of about $243.58 million, CapsoVision, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-6.38). Key stats such as the average daily volume over the past year has been around 357.27 thousand shares, volume is running light vs its 52-week average. Headquartered in Saratoga, CA, CapsoVision, Inc. operates in the Healthcare sector and the Medical - Equipment & Services industry. Led by CEO Kang Huai Wang, the company employs approximately 90 people and listed since September 03, 2001. Medical‑technology company developing advanced capsule endoscopy systems (CapsoCam Plus, CapsoCam Colon) and AI-enabled imaging platforms for gastrointestinal diagnostics

CapsoVision, Inc. trades at a P/E ratio of -13.09, slightly below the S&P 500 average, with a price-to-sales ratio of 24.68 and a price-to-book ratio of 11.48 reflecting a rich premium to book value. The P/FCF stands at -15.58, also above market averages. Compared to sector medians, CapsoVision, Inc. P/S is trading rich, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.